Xtalks

📬 Stay ahead with expert insights, job opportunities, and must-attend life science webinars in the November 2024 edition of the Xtalks Community Connection newsletter! 🌟 This month, we’re covering key topics in clinical trials, drug development, and pharma manufacturing. Hear experts discuss current industry challenges and explore the impact of digitized protocols, and catch our top 10 pharma/biotech layoffs of 2024 — all this and more below ⬇️

Navigating early-phase clinical trials, including First-in-Human (FIH) studies, is crucial for biotech and MedTech companies seeking FDA approval. Challenges like regulatory requirements and data management can impede progress. Join our webinar by Medrio to learn strategies for overcoming these hurdles, including optimizing trial design, selecting technology solutions, and ensuring data quality. Discover how effective data management enhances efficiency and strengthens reimbursement cases, with real-world examples to highlight successful strategies. Register here: https://buff.ly/3YwFVVu #ClinicalTrials #Biotech #MedTech #Webinar #FDAApproval

📰 LumiThera, Inc. has received FDA authorization for its Valeda Light Delivery System for dry AMD. Read more at https://buff.ly/4feB6Hf by Ayesha Rashid about the system, which is the first FDA-authorized treatment for vision loss in patients with the condition.

The shift to real-world evidence (RWE) is transforming drug development in the pharmaceutical industry. Accurate monitoring of arterial health is crucial for assessing therapy effectiveness, especially for cardiovascular disease and diabetes. Join our webinar by Cardiex to learn how CONNEQT Pulse enables companies to collect precise RWE, using central blood pressure and pulse wave analysis (PWA) to inform decisions from trials to post-market surveillance. Discover how CONNEQT Pulse can enhance clinical trials and improve therapeutic outcomes: https://buff.ly/3UD7Q4G #Pharmaceuticals #RealWorldEvidence #Webinar #CardiovascularHealth

In this episode, hear about Envoy Medical ’s innovative hearing solutions from company CEO Brent Lucas, as well as how to protect hearing and the Hearing Device Coverage Clarification Act. Listen now at https://buff.ly/3YUkS0a 🎙️

📰 Discover how Gelteq's IPO is set to help expand gel-based drug delivery innovations, from pain management to personalized nutraceuticals. Learn how their proprietary gel tech is tackling challenges in swallowing and bioavailability by Soumya Shashikumar at https://buff.ly/3ADwuve.

📰 After groundbreaking successes in diabetes and obesity, Novo Nordisk is taking its GLP-1 drug Wegovy to MASH. Last week, the company shared promising findings from the first part of a clinical trial evaluating the drug for the treatment of the chronic liver condition. Read more at https://buff.ly/48EcTI0 by Ayesha Rashid.

Commercializing a new medicine is complex, with the first six months crucial for success. Many companies struggle with launch planning. Join our webinar by Inceptua Group to discover how early access programs can enhance engagement with the medical community and refine commercial strategies. These programs help companies assess market demand while giving patients access to promising medicines before launch, improving their quality of life. Experts will share best practices for integrating early access during clinical phases II and III to strengthen commercialization efforts. Register now to learn how early access programs can drive successful pharmaceutical launches: https://buff.ly/3AsbrvB #Pharmaceuticals #Webinar #Commercialization #EarlyAccess #Healthcare